skip to Main Content

Free Newsletter: Actionable insight every morning for the self-directed investor. Find out more

Three things you need to know in the financial markets this morning from investment writer, Tony Cross.

World High Life

Slim pickings in corporate news this morning, but Aquis-listed World High Life [AQSE:LIFE] has reported a sharp increase in July’s sales figures for its London-based CBD brand, Love Hemp. Income was up 57% year-on-year, with online channels continuing to perform well. The company notes that consumers are increasingly turning to natural health remedies to cope with anxiety, something which has understandably been elevated during the COVID pandemic.

Avon Rubber

Avon Rubber [LON:AVON] has today updated the market with news of a contract award for the NATO Procurement Agency. This is to supply a range of masks and air filtration systems, runs for 10 years and will start having an impact on the bottom line in the 2021 financial year. No details of the value of the contract are available.

Fusion Antibodies

One company that caught the eye this morning was Fusion Antibodies [LON:FAB] with its final results. As the name hints, they are playing a part in the fight to find a solution for COVID-19. The company has recently introduced a new service, which can improve the structure and performance of antibody-based drugs. That’s helped drive revenues up from £2.2m to £3.9m, whilst also cutting losses from £1.3m to £0.7m. This could warrant a closer look at the full statement.

Sign up for three quick facts and more with our Free Daily Digest newsletter, every weekday morning.

Become a better investor with SharePad Designed to give you the confidence to pick your own investments, Sharepad gives you access to a wealth of information on UK, US & European stocks. Find out more

Please note this article does not constitute investment advice. Investors are encouraged to do their own research beforehand or consult a professional advisor.

Tony Cross

Tony Cross

Tony Cross is a market commentator with over 15 years of experience, producing compelling, insightful copy for journalists and investors alike. Focusing on macroeconomics, UK blue chip equities and inter market analysis, Cross's commentary is well regarded for its clarity and ability to cut through the waffle. He has been quoted in publications as diverse as The Financial Times, The Times, The Guardian and The Sun. He has also been a regular guest on both Share Radio and TipTV.

Stocks in Focus

Here are some of the smaller companies we are following most closely. They all represent significant growth stories in our view. Our in-depth reports go into more detail on why we like them.


Back To Top